Investigating the Effect of Sub-Tonsillar Marcaine Injection for Reducing Postoperative Nausea and Vomiting

Phase 3

Recruiting

• Conditions: Chronic tonsillitis.; Chronic tonsillitis; J35.01

• Registration Number: IRCT20191016045134N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients candidate for tonsillectomy surgery
Age group 5 to 12 years

Exclusion Criteria

Patients with history of bronchitis and asthma
Patients with history of cardiovascular, liver and hematologic diseases
Allergic reaction to Bupivacaine or Lidocain
Patient with history or presence of coagulation disorder (Coagulopathy)
Symptoms of acute pharyngitis
Acute respiratory infections
The presence of fever

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative pain. Timepoint: 1, 4, 8, 16 and 24 hours after drug injection. Method of measurement: Visual Analogue Scale (VAS).;Incidence of nausea. Timepoint: 1, 4, 8, 16 and 24 hours after drug injection. Method of measurement: By scoring in none (1), low (2), moderate (3) and Severe (4).;Incidence of vomiting. Timepoint: 1, 4, 8, 16 and 24 hours after drug injection. Method of measurement: By scoring in none (1), low (2), moderate (3) and Severe (4).;Agitation score. Timepoint: 1, 4, 8, 16 and 24 hours after drug injection. Method of measurement: By scoring in none (1), low (2), moderate (3) and Severe (4).